Ichthyosis is a group of hereditary skin disorders characterized by dry, thickened skin with scales. It results from mutations in genes involved in skin barrier function, leading to defects in keratinization and desquamation (natural skin shedding).
The main types and their prevalence are as follows.
Type
Prevalence
Inheritance
Ichthyosis vulgaris
1/250
Autosomal dominant
X-linked ichthyosis
1/2,000 to 1/6,000 males
X-linked recessive
Lamellar ichthyosis
1/100,000 to 1/300,000
Autosomal recessive
Harlequin ichthyosis
1/1,000,000
Autosomal recessive
Ichthyosis is primarily a skin disease, but it can also cause various ocular complications. Ocular symptoms are mainly related to abnormalities of the eyelids and tear film, which can lead to exposure keratopathy. In particular, lamellar ichthyosis and congenital ichthyosiform erythroderma cause hardening and loss of flexibility of the skin around the eyelids, resulting in a high incidence of ectropion and lagophthalmos1).
In X-linked ichthyosis (XLI), accumulation of cholesterol sulfate due to steroid sulfatase deficiency leads to characteristic corneal findings (macular corneal dystrophy and stromal opacities)2,4). Thus, the ocular impact varies greatly depending on the type of ichthyosis.
QDoes ichthyosis always affect the eyes?
A
The impact on the eyes varies greatly depending on the type of ichthyosis. In the most common type, ichthyosis vulgaris, eye involvement is often mild, usually limited to punctate keratitis. In contrast, lamellar ichthyosis causes ectropion in up to 50% of cases, increasing the risk of exposure keratopathy. X-linked ichthyosis shows characteristic corneal changes. Regular eye examinations are recommended for all types.
Ectropion: The lower eyelid turns outward, exposing the conjunctiva and cornea. It occurs in up to 50% of lamellar ichthyosis cases, and almost all cases with TGM1 mutations are associated with eyelid margin abnormalities3,6)
Lagophthalmos: Incomplete eyelid closure. Caused by hardening of the skin around the eyelids.
Blepharitis: Chronic inflammation of the eyelid margins. Caused by accumulation of scales.
Trichiasis: Eyelashes turn toward the cornea, damaging the ocular surface.
In X-linked ichthyosis, slit-lamp microscopy may reveal prominent corneal nerves. This is a characteristic finding associated with steroid sulfatase deficiency, and at high magnification, punctate stromal deposits due to cholesterol sulfate accumulation can also be observed 4). Cornea farinata is usually asymptomatic and does not affect vision, but it is important as a finding suggesting the presence of a metabolic disorder. In a study of 38 cases by Costagliola et al., the incidence of corneal opacity in XLI patients was approximately 23.7%, similar to that in carrier mothers (24.3%), indicating that the presence or absence of opacity alone cannot confirm the diagnosis of XLI 2).
Regarding the application of advanced imaging techniques such as optical coherence tomography angiography (OCTA), reports specific to ichthyosis are currently limited.
QWhat are the characteristic ocular findings in X-linked ichthyosis?
A
In X-linked ichthyosis (XLI), deficiency of the steroid sulfatase enzyme leads to accumulation of cholesterol sulfate in the corneal stroma. This results in prominent corneal nerves, punctate stromal deposits, and a fine dust-like stromal opacity called cornea farinata observed on slit-lamp microscopy. Cornea farinata is usually asymptomatic and does not affect vision, but it is an important clue for diagnosing the underlying disease.
Each type of ichthyosis involves specific genetic mutations.
Ichthyosis vulgaris: Mutations in the filaggrin gene (FLG). It causes skin barrier dysfunction. Autosomal dominant inheritance, and it is the most common type.
X-linked ichthyosis: Mutations in the steroid sulfatase gene (STS). Impaired degradation of cholesterol sulfate leads to accumulation in the skin and cornea. It occurs only in males.
Lamellar ichthyosis: Multiple gene mutations involved in lipid metabolism. TGM1 (transglutaminase 1) is the most common. Autosomal recessive inheritance.
Harlequin ichthyosis: Mutation in the ABCA12 gene. The most severe type, presenting with abnormal lamellar granules and severe hyperkeratosis.
The diagnosis of ichthyosis is based on clinical evaluation. The type is estimated from the characteristic scaly skin appearance and distribution pattern over large areas of the body. Genetic testing is useful for a definitive diagnosis, and identification of specific gene mutations can confirm the type. Histopathological examination reveals findings characteristic of each type, such as orthokeratotic hyperkeratosis, changes in the granular layer, and accumulation of cholesterol sulfate.
Correction of ectropion: Indicated when conservative treatment is insufficient. Procedures such as lateral tarsal strip restore normal eyelid position and resolve corneal exposure.
Treatment of trichiasis: Regular epilation of misdirected lashes. For recurrent cases, consider permanent removal by electrolysis or cryotherapy.
Punctal plugs: When tear volume is insufficient, punctal occlusion reduces tear drainage.
QWhen is surgery considered for ectropion in ichthyosis?
A
Surgical correction is considered when symptoms due to corneal exposure (dryness, redness, pain, corneal erosion/ulcer, etc.) cannot be controlled with adequate conservative treatment such as artificial tears, eye ointments, and moisture goggles. In particular, early surgical intervention is recommended when corneal ulcers recur or when visual acuity decline progresses. Regular ophthalmologic follow-up after surgery is essential.
The basic pathology of ichthyosis is skin barrier dysfunction. Genetic mutations impair the keratinization process, leading to the formation of abnormal stratum corneum. Normal desquamation is inhibited, resulting in accumulation of scales and hardening of the skin.
When the skin around the eyelids is affected by this process, elasticity is lost and ectropion occurs. In lamellar ichthyosis and harlequin ichthyosis, hyperkeratosis is particularly severe, so ectropion may appear immediately after birth 3,5). Ectropion causes exposure of the conjunctiva and cornea, leading to chronic dryness and corneal epithelial damage (exposure keratopathy), which can progress to corneal ulceration or perforation if left untreated 1,5).
In X-linked ichthyosis, steroid sulfatase (STS) enzyme is deficient. This enzyme converts cholesterol sulfate to free cholesterol. Due to the enzyme deficiency, cholesterol sulfate accumulates not only in the skin but also in the cornea.
Accumulation of cholesterol sulfate in the cornea leads to the following findings:
Punctate deposits in the corneal stroma: Fine deposits distributed from Bowman’s layer to the deep stroma
Corneal verticillata: Fine dust-like opacities on the anterior surface of Descemet’s membrane. Usually asymptomatic.
Prominent corneal nerves: Deposits along nerve fibers make corneal nerves more visible on slit-lamp examination.
These changes reflect metabolic abnormalities and usually do not affect vision. However, they are important clues for the diagnosis of XLI. Macsai et al. reported cases in which thickening of the epithelial basement membrane and abnormal protein deposition in Bowman’s layer were confirmed pathologically 4).
In ichthyosis, abnormal keratinization of the entire skin also affects the meibomian glands. The openings of the meibomian glands become obstructed by keratinous material, impairing lipid secretion. A decrease in the lipid layer of the tear film leads to increased tear evaporation, resulting in evaporative dry eye. This is a common problem regardless of the type of ichthyosis.
Ichthyosis has been reported as a condition associated with keratoconus. Keratoconus is a corneal thinning caused by degradation of corneal collagen, and changes in enzyme activity and oxidative stress have been proposed as causative factors. Abnormalities in corneal structure in ichthyosis may contribute to this disease susceptibility, but the detailed mechanism remains a subject for future research.
Potential for Gene Therapy and Molecular Targeted Therapy
For types of ichthyosis in which the causative gene has been identified, the development of gene therapy and molecular targeted therapy is expected in the future. If fundamental improvement of skin barrier function is achieved, it may also lead to prevention of ocular complications.
Large-scale studies specifically focusing on ocular complications of ichthyosis are still limited. Accumulation of data on the exact prevalence of ocular complications in each type, optimal intervals for ophthalmic screening, and long-term prognosis is needed.
Al-Amry MA. Ocular manifestation of Ichthyosis. Saudi J Ophthalmol. 2016;30(1):39-43. PMID: 26949357. PMCID: PMC4759502.
Costagliola C, Fabbrocini G, Illiano GM, Scibelli G, Delfino M. Ocular findings in X-linked ichthyosis: a survey on 38 cases. Ophthalmologica. 1991;202(3):152-155. PMID: 1923309.
Singh AJ, Atkinson PL. Ocular manifestations of congenital lamellar ichthyosis. Eur J Ophthalmol. 2005;15(1):118-122. PMID: 15751249.
Macsai MS, Doshi H. Clinical pathologic correlation of superficial corneal opacities in X-linked ichthyosis. Am J Ophthalmol. 1994;118(4):477-484. PMID: 7943126.
Yeoh BJ, Nanthini S. Ophthalmic Review on Neonatal Harlequin Ichthyosis. Cureus. 2023;15(8):e44320. PMID: 37779732. PMCID: PMC10538354.
Macriz-Romero N, Vera-Duarte GR, Guerrero-Becerril J, Chacón-Camacho OF, Astiazarán MC, Zenteno JC, Graue-Hernandez EO. Ophthalmic findings in patients with autosomal recessive lamellar ichthyosis due to TGM1 mutations in an isolated population. Int Ophthalmol. 2023;43(10):3659-3665. PMID: 37542530.
Copy the article text and paste it into your preferred AI assistant.
Article copied to clipboard
Open an AI assistant below and paste the copied text into the chat box.